Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Acrivon Therapeutics
Acrivon Therapeutics
IPOs fail to bounce back in Q4
EP Vantage
Thu, 01/5/23 - 10:16 am
IPOs
Prime Medicine
Acrivon Therapeutics
Lipella Pharmaceuticals
Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds
MedCity News
Sun, 11/20/22 - 12:37 pm
Acrivon Therapeutics
Eli Lilly
IPOs
Proteomics
cancer
oncology
Acrivon Becomes Biotech's 20th IPO of 2022 with $99M Offering
BioSpace
Tue, 11/15/22 - 06:36 pm
Acrivon Therapeutics
IPOs
A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma Dive
Wed, 10/19/22 - 10:39 am
Acrivon Therapeutics
IPOs
Eli Lilly
prexasertib
ovarian cancer
endometrial cancer
bladder cancer
precision medicine
With $100M, startup to bring Lilly-licensed drug into trials
Bizjournals
Thu, 11/11/21 - 11:05 am
Acrivon Therapeutics
Eli Lilly
clinical trials